AAAAAA

   
Results: 1-11 |
Results: 11

Authors: GOLAB J STOKLOSA T ZAGOZDZON R KACA A KULCHITSKA LA FELESZKO W KAWIAK J HOSER G GLOWACKA E DABROWSKA A GIERMASZ A LASEK W JAKOBISIAK M
Citation: J. Golab et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR POTENTIATES ANTITUMOR-ACTIVITY OF INTERLEUKIN-12 IN MELANOMA MODEL IN MICE, Tumor biology, 19(2), 1998, pp. 77-87

Authors: GOLAB J STOKLOSA T ZAGOZDZON R KACA A GIERMASZ A POJDA Z MACHAJ E DABROWSKA A FELESZKO W LASEK W IWANOSIECKA A JAKOBISIAK M
Citation: J. Golab et al., G-CSF PREVENTS THE SUPPRESSION OF BONE-MARROW HEMATOPOIESIS INDUCED BY IL-12 AND AUGMENTS ITS ANTITUMOR-ACTIVITY IN A MELANOMA MODEL IN MICE, Annals of oncology, 9(1), 1998, pp. 63-69

Authors: GOLAB J ZAGOZDZON R STOKLOSA T KACA A DABROWSKA A GIERMASZ A FELESZKO W JAKOBISIAK M
Citation: J. Golab et al., GRANULOCYTE-COLONY-STIMULATING FACTOR DEMONSTRATES ANTITUMOR-ACTIVITYIN MELANOMA MODEL IN MICE, Neoplasma, 45(1), 1998, pp. 35-39

Authors: ZAGOZDZON R GOLAB J STOKLOSA T GIERMASZ A NOWICKA D FELESZKO W LASEK W JAKOBISIAK M
Citation: R. Zagozdzon et al., EFFECTIVE CHEMOIMMUNOTHERAPY OF L1210 LEUKEMIA IN-VIVO USING INTERLEUKIN-12 COMBINED WITH DOXORUBICIN BUT NOT WITH CYCLOPHOSPHAMIDE, PACLITAXEL OR CISPLATIN, International journal of cancer, 77(5), 1998, pp. 720-727

Authors: GOLAB J ZAGOZDZON R STOKLOSA T LASEK W JAKOBISIAK M POJDA Z MACHAJ E
Citation: J. Golab et al., ERYTHROPOIETIN PREVENTS THE DEVELOPMENT OF INTERLEUKIN-12-INDUCED ANEMIA AND THROMBOCYTOPENIA BUT DOES NOT DECREASE ITS ANTITUMOR-ACTIVITY IN MICE, Blood, 91(11), 1998, pp. 4387-4388

Authors: WOJCIK C STOKLOSA T GIERMASZ A GOLAB J ZAGOZDZON R KAWIAK J WILK S KOMAR A KACA A MALEJCZYK J JAKOBISIAK M
Citation: C. Wojcik et al., APOPTOSIS INDUCED IN L1210 LEUKEMIA-CELLS BY AN INHIBITOR OF THE CHYMOTRYPSIN-LIKE ACTIVITY OF THE PROTEASOME, Apoptosis, 2(5), 1997, pp. 455-462

Authors: LASEK W FELESZKO W GOLAB J STOKLOSA T MARCZAK M DABROWSKA A MALEJCZYK M JAKOBISIAK M
Citation: W. Lasek et al., ANTITUMOR EFFECTS OF THE COMBINATION IMMUNOTHERAPY WITH INTERLEUKIN-12 AND TUMOR-NECROSIS-FACTOR-ALPHA IN MICE, European journal of cancer, 33, 1997, pp. 22-22

Authors: LASEK W FELESZKO W GOLAB J STOKLOSA T MARCZAK M DABROWSKA A MALEJCZYK M JAKOBISIAK M
Citation: W. Lasek et al., ANTITUMOR EFFECTS OF THE COMBINATION IMMUNOTHERAPY WITH INTERLEUKIN-12 AND TUMOR-NECROSIS-FACTOR-ALPHA IN MICE, Cancer immunology and immunotherapy, 45(2), 1997, pp. 100-108

Authors: ZAGOZDZON R STOKLOSA T GOLAB J GIERMASZ A DABROWSKA A LASEK W JAKOBISIAK M
Citation: R. Zagozdzon et al., AUGMENTED ANTITUMOR EFFECTS OF COMBINATION THERAPY WITH INTERLEUKIN-12, CISPLATIN, AND TUMOR-NECROSIS-FACTOR-ALPHA IN A MURINE MELANOMA MODEL, Anticancer research, 17(6D), 1997, pp. 4493-4498

Authors: LASEK W GIERMASZ A KUC K WANKOWICZ A FELESZKO W GOLAB J ZAGOZDZON R STOKLOSA T JAKOBISIAK M
Citation: W. Lasek et al., POTENTIATION OF THE ANTITUMOR EFFECT OF ACTINOMYCIN-D BY TUMOR-NECROSIS-FACTOR-ALPHA IN MICE - CORRELATION BETWEEN IN-VITRO AND IN-VIVO RESULTS, International journal of cancer, 66(3), 1996, pp. 374-379

Authors: LASEK W JAKOBISIAK M STOKLOSA T
Citation: W. Lasek et al., DECREASED NATURAL-KILLER-CELL ACTIVITY IN WHOLE-BLOOD DONORS DOES NOTSEEM TO RESULT IN INCREASED CANCER INCIDENCE, Transfusion, 34(4), 1994, pp. 359-360
Risultati: 1-11 |